Clinical Trials Directory

Trials / Completed

CompletedNCT00018200

Effect of Antidepressants on Back Pain

Efficacy of Antidepressants in Chronic Back Pain

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
130 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.

Conditions

Interventions

TypeNameDescription
DRUGDesipramineLow exposure (40-70 ng/mL), Middle exposure (70-130 ng/mL), High exposure (130-200 ng/mL)
DRUGFluoxetineLow exposure (200-399 ng/mL), Middle exposure (400-499 ng/mL), High exposure (500-700ng/mL)
DRUGBenztropineDaily dose 0.125 to 0.5mg

Timeline

Start date
1999-04-01
Primary completion
2003-12-01
Completion
2004-03-01
First posted
2001-07-05
Last updated
2012-06-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00018200. Inclusion in this directory is not an endorsement.

Effect of Antidepressants on Back Pain (NCT00018200) · Clinical Trials Directory